H.U. Group

Top Message

Our company was originally established in 1950 as Fujizoki-Pharmaceutical. Since then, we have been growing as a corporate group focusing on clinical laboratory testing and in vitro diagnostics.

In 2020, 70 years since our establishment, we changed our name to “H.U. Group Holdings” (the H.U. expresses our slogan: Healthcare for You), with the goal of contributing further to the development of healthcare. In this way, we have taken a new step forward toward the realization of sustainable growth.

During the COVID-19 pandemic, we came together as a group to contribute to infection prevention countermeasures in Japan. By steadily implementing our Group Integration, we were able to launch polymerase chain reaction (PCR) testing ahead of our competitors and develop the world’s first highsensitivity quantitative antigen test reagent.

Meanwhile, we have been accelerating our Group Integration by combining the sales and marketing functions and R&D functions of our core businesses. We have also been promoting business restructuring throughout the Group with the goal of becoming more resilient and innovative. By further enhancing these activities, we will move closer to realizing the Group’s Mission of “Create new value in healthcare and thereby contribute to human health and the future of medical care.”

Please expect great things from our Group as we continue to pursue new possibilities in healthcare.

Shigekazu Takeuchi | Chairman, President and Group CEO | H.U. Group Holdings, Inc.